Neuren Pharmaceuticals News and Activities

Neuren Pharmaceuticals is one of the...

• Russell 3000;
• S&P/ASX200;
• TOB Iconic 10,000.

Neuren Pharmaceuticals is a company listed under the stock ticker NEU (AU).

View the org chart displaying its 18 main executives

Most searched biographies at Neuren Pharmaceuticals

• Jon Pilcher, Chief Executive Officer and Director
• Patrick Davies, Non-Executive Director
• Joe Basile, Non-Executive Director

Create your alert
to follow the executive moves at Neuren Pharmaceuticals.

Neuren Pharmaceuticals has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Neuren Pharmaceuticals

• News & Reports | Neuren Pharmaceuticals

Social media about Neuren Pharmaceuticals

• Neuren Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Neuren Pharmaceuticals on LinkedIn, X (Twitter) & YouTube